Cargando…

Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment

Post-stroke depression and cognitive impairment are common conditions affecting patients after stroke. Serotonin is a neurotransmitter involved in modulating, among others, mood, cognition, learning, and memory. Sub-optimal serotonin activity may be in part responsible for cognitive deficits seen in...

Descripción completa

Detalles Bibliográficos
Autores principales: Siotto, Mariacristina, Germanotta, Marco, Santoro, Massimo, Cipollini, Valeria, Guardati, Giulia, Papadopoulou, Dionysia, Bray, Elisa, Mastrorosa, Alessia, Aprile, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156601/
https://www.ncbi.nlm.nih.gov/pubmed/34063444
http://dx.doi.org/10.3390/brainsci11050642
_version_ 1783699483852275712
author Siotto, Mariacristina
Germanotta, Marco
Santoro, Massimo
Cipollini, Valeria
Guardati, Giulia
Papadopoulou, Dionysia
Bray, Elisa
Mastrorosa, Alessia
Aprile, Irene
author_facet Siotto, Mariacristina
Germanotta, Marco
Santoro, Massimo
Cipollini, Valeria
Guardati, Giulia
Papadopoulou, Dionysia
Bray, Elisa
Mastrorosa, Alessia
Aprile, Irene
author_sort Siotto, Mariacristina
collection PubMed
description Post-stroke depression and cognitive impairment are common conditions affecting patients after stroke. Serotonin is a neurotransmitter involved in modulating, among others, mood, cognition, learning, and memory. Sub-optimal serotonin activity may be in part responsible for cognitive deficits seen in depression. In this pilot study serotonin levels were evaluated in 29 patients with sub-acute stroke before and after a rehabilitation treatment (consisting of a program of upper limb robotic rehabilitation in addition to conventional physical therapy treatment). We employed the Back Depression Inventory scale to evaluate symptoms of depression, and specific tools to evaluate cognitive functions. We found a significant reduction of the serotonin levels after rehabilitation in the whole group (T0: 85.9 ± 92.4 ng/mL; T1: 61.9 ± 58.4 ng/mL; p = 0.0018), as well as in the subgroup of patients untreated with Selective Serotonin Reuptake Inhibitors (SRRI), (mean serotonin at T0: 154.0 ± 102.3 ng/mL; mean serotonin at T1: 92.9. ± 68.7 ng/mL at T1; p = 0.005). We also found a correlation with cognitive assessment: in particular, the change from baseline of the serotonin (ΔSerotonin) was correlated with the changes from baseline of the Rey’s Figure (ΔROCF) (r = 0.535; p < 0.05), the Tower of London (ΔToL) (subscore point: r = 0.621; p < 0.005; subscore time: r = −0.619; p < 0.005) meaning that a serotonin levels decrease is associated with a worsening of cognitive functions. Considering patients treated and untreated with SSRIs separately, in patients treated with SSRIs (n = 16) we found only a positive correlation between ∆Serotonin and ∆ToL (subscore point: r= 0.587; p = 0.045), whereas in patients untreated with SSRIs (n = 13) we found a positive correlations between ΔSerotonin and ΔROCF (r = 0.700; p = 0.036), ∆Stroop (subscore time: r = 0.750; p = 0.020) and ∆Tol (subscore point: r = 0.740; p = 0.023) and a negative correlation between ΔSerotonin and ∆Tol (subscore time: r= −0.833; p = 0.005). These results suggest that variation of serotonin levels should be monitored in patients during a rehabilitation program, not only for their relationship with depression symptoms, but also for the correlation with cognitive performance.
format Online
Article
Text
id pubmed-8156601
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81566012021-05-28 Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment Siotto, Mariacristina Germanotta, Marco Santoro, Massimo Cipollini, Valeria Guardati, Giulia Papadopoulou, Dionysia Bray, Elisa Mastrorosa, Alessia Aprile, Irene Brain Sci Article Post-stroke depression and cognitive impairment are common conditions affecting patients after stroke. Serotonin is a neurotransmitter involved in modulating, among others, mood, cognition, learning, and memory. Sub-optimal serotonin activity may be in part responsible for cognitive deficits seen in depression. In this pilot study serotonin levels were evaluated in 29 patients with sub-acute stroke before and after a rehabilitation treatment (consisting of a program of upper limb robotic rehabilitation in addition to conventional physical therapy treatment). We employed the Back Depression Inventory scale to evaluate symptoms of depression, and specific tools to evaluate cognitive functions. We found a significant reduction of the serotonin levels after rehabilitation in the whole group (T0: 85.9 ± 92.4 ng/mL; T1: 61.9 ± 58.4 ng/mL; p = 0.0018), as well as in the subgroup of patients untreated with Selective Serotonin Reuptake Inhibitors (SRRI), (mean serotonin at T0: 154.0 ± 102.3 ng/mL; mean serotonin at T1: 92.9. ± 68.7 ng/mL at T1; p = 0.005). We also found a correlation with cognitive assessment: in particular, the change from baseline of the serotonin (ΔSerotonin) was correlated with the changes from baseline of the Rey’s Figure (ΔROCF) (r = 0.535; p < 0.05), the Tower of London (ΔToL) (subscore point: r = 0.621; p < 0.005; subscore time: r = −0.619; p < 0.005) meaning that a serotonin levels decrease is associated with a worsening of cognitive functions. Considering patients treated and untreated with SSRIs separately, in patients treated with SSRIs (n = 16) we found only a positive correlation between ∆Serotonin and ∆ToL (subscore point: r= 0.587; p = 0.045), whereas in patients untreated with SSRIs (n = 13) we found a positive correlations between ΔSerotonin and ΔROCF (r = 0.700; p = 0.036), ∆Stroop (subscore time: r = 0.750; p = 0.020) and ∆Tol (subscore point: r = 0.740; p = 0.023) and a negative correlation between ΔSerotonin and ∆Tol (subscore time: r= −0.833; p = 0.005). These results suggest that variation of serotonin levels should be monitored in patients during a rehabilitation program, not only for their relationship with depression symptoms, but also for the correlation with cognitive performance. MDPI 2021-05-15 /pmc/articles/PMC8156601/ /pubmed/34063444 http://dx.doi.org/10.3390/brainsci11050642 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Siotto, Mariacristina
Germanotta, Marco
Santoro, Massimo
Cipollini, Valeria
Guardati, Giulia
Papadopoulou, Dionysia
Bray, Elisa
Mastrorosa, Alessia
Aprile, Irene
Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title_full Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title_fullStr Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title_full_unstemmed Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title_short Serotonin Levels and Cognitive Recovery in Patients with Subacute Stroke after Rehabilitation Treatment
title_sort serotonin levels and cognitive recovery in patients with subacute stroke after rehabilitation treatment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156601/
https://www.ncbi.nlm.nih.gov/pubmed/34063444
http://dx.doi.org/10.3390/brainsci11050642
work_keys_str_mv AT siottomariacristina serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT germanottamarco serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT santoromassimo serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT cipollinivaleria serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT guardatigiulia serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT papadopouloudionysia serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT brayelisa serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT mastrorosaalessia serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment
AT aprileirene serotoninlevelsandcognitiverecoveryinpatientswithsubacutestrokeafterrehabilitationtreatment